カテゴリ： Market Monitor Global, 世界, 医療/バイオ

非ステロイド性抗炎症薬（NSAID）のグローバル市場展望 2023年-2029年：サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬

■ 英語タイトル：Non-steroidal Anti-inflammatory Drugs (NSAID) Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5813）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5813
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥481,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥625,300見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥721,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[非ステロイド性抗炎症薬（NSAID）のグローバル市場展望 2023年-2029年：サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の非ステロイド性抗炎症薬（NSAID）市場規模と予測を収録しています。・世界の非ステロイド性抗炎症薬（NSAID）市場：売上、2018年-2023年、2024年-2029年
・世界の非ステロイド性抗炎症薬（NSAID）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非ステロイド性抗炎症薬（NSAID）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「サリチル酸塩」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

非ステロイド性抗炎症薬（NSAID）のグローバル主要企業は、Bayer、 Ecotrin、 Generic、 St. Joseph、 Elanco、 Zoetis、 Boehringer Ingelheim、 Merial、 Merck Animal Healthなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、非ステロイド性抗炎症薬（NSAID）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の非ステロイド性抗炎症薬（NSAID）市場：タイプ別、2018年-2023年、2024年-2029年
世界の非ステロイド性抗炎症薬（NSAID）市場：タイプ別市場シェア、2022年
・サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬

世界の非ステロイド性抗炎症薬（NSAID）市場：用途別、2018年-2023年、2024年-2029年
世界の非ステロイド性抗炎症薬（NSAID）市場：用途別市場シェア、2022年
・人間、動物、その他

世界の非ステロイド性抗炎症薬（NSAID）市場：地域・国別、2018年-2023年、2024年-2029年
世界の非ステロイド性抗炎症薬（NSAID）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における非ステロイド性抗炎症薬（NSAID）のグローバル売上、2018年-2023年
・主要企業における非ステロイド性抗炎症薬（NSAID）のグローバル売上シェア、2022年
・主要企業における非ステロイド性抗炎症薬（NSAID）のグローバル販売量、2018年-2023年
・主要企業における非ステロイド性抗炎症薬（NSAID）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bayer、 Ecotrin、 Generic、 St. Joseph、 Elanco、 Zoetis、 Boehringer Ingelheim、 Merial、 Merck Animal Health

*************************************************************

・調査・分析レポートの概要
非ステロイド性抗炎症薬（NSAID）市場の定義
市場セグメント
世界の非ステロイド性抗炎症薬（NSAID）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非ステロイド性抗炎症薬（NSAID）市場規模
世界の非ステロイド性抗炎症薬（NSAID）市場規模：2022年 VS 2029年
世界の非ステロイド性抗炎症薬（NSAID）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非ステロイド性抗炎症薬（NSAID）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非ステロイド性抗炎症薬（NSAID）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬
非ステロイド性抗炎症薬（NSAID）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：人間、動物、その他
非ステロイド性抗炎症薬（NSAID）の用途別グローバル売上・予測

・地域別市場分析
地域別非ステロイド性抗炎症薬（NSAID）市場規模 2022年と2029年
地域別非ステロイド性抗炎症薬（NSAID）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 Ecotrin、 Generic、 St. Joseph、 Elanco、 Zoetis、 Boehringer Ingelheim、 Merial、 Merck Animal Health
...

This report aims to provide a comprehensive presentation of the global market for Non-steroidal Anti-inflammatory Drugs (NSAID), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-steroidal Anti-inflammatory Drugs (NSAID). This report contains market size and forecasts of Non-steroidal Anti-inflammatory Drugs (NSAID) in global, including the following market information:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Non-steroidal Anti-inflammatory Drugs (NSAID) companies in 2022 (%)
The global Non-steroidal Anti-inflammatory Drugs (NSAID) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Salicylates Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial and Merck Animal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Type, 2022 (%)
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Application, 2022 (%)
Human
Animals
Others
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues share in global market, 2022 (%)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-steroidal Anti-inflammatory Drugs (NSAID), market overview.
Chapter 2: Global Non-steroidal Anti-inflammatory Drugs (NSAID) market size in revenue and volume.
Chapter 3: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-steroidal Anti-inflammatory Drugs (NSAID) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Overall Market Size
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2022 VS 2029
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales: 2018-2029
3 Company Landscape
3.1 Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.2 Top Global Non-steroidal Anti-inflammatory Drugs (NSAID) Companies Ranked by Revenue
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.8.1 List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Markets, 2022 & 2029
4.1.2 Salicylates
4.1.3 Propionic acid derivatives
4.1.4 Acetic acid derivatives
4.1.5 Enolic acid (Oxicam) derivatives
4.1.6 Anthranilic acid derivatives (Fenamates)
4.1.7 Selective COX-2 inhibitors (Coxibs)
4.1.8 Sulfonanilides
4.2 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
4.2.1 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
4.2.2 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2029
4.2.3 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
4.3 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
4.3.1 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
4.3.2 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2029
4.3.3 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
4.4 By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2022 & 2029
5.1.2 Human
5.1.3 Animals
5.1.4 Others
5.2 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
5.2.1 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
5.2.2 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2029
5.2.3 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
5.3 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
5.3.1 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
5.3.2 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2029
5.3.3 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
5.4 By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2022 & 2029
6.2 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
6.2.1 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
6.2.2 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2029
6.2.3 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2029
6.3 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
6.3.1 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
6.3.2 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2029
6.3.3 By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.4.2 By Country – North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.4.3 US Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.4.4 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.4.5 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.5.2 By Country – Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.5.3 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.4 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.5 U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.6 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.7 Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.8 Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.5.9 Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.6.2 By Region – Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.6.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6.5 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6.6 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.6.7 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.7.2 By Country – South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.7.3 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.7.4 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2029
6.8.3 Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.8.4 Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.8.5 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
6.8.6 UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Ecotrin
7.2.1 Ecotrin Company Summary
7.2.2 Ecotrin Business Overview
7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.2.5 Ecotrin Key News & Latest Developments
7.3 Generic
7.3.1 Generic Company Summary
7.3.2 Generic Business Overview
7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.3.5 Generic Key News & Latest Developments
7.4 St. Joseph
7.4.1 St. Joseph Company Summary
7.4.2 St. Joseph Business Overview
7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.4.5 St. Joseph Key News & Latest Developments
7.5 Elanco
7.5.1 Elanco Company Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.5.5 Elanco Key News & Latest Developments
7.6 Zoetis
7.6.1 Zoetis Company Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.6.5 Zoetis Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Merial
7.8.1 Merial Company Summary
7.8.2 Merial Business Overview
7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.8.5 Merial Key News & Latest Developments
7.9 Merck Animal Health
7.9.1 Merck Animal Health Company Summary
7.9.2 Merck Animal Health Business Overview
7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.9.5 Merck Animal Health Key News & Latest Developments
8 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, Analysis
8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, 2018-2029
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-steroidal Anti-inflammatory Drugs (NSAID) Supply Chain Analysis
10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Market
10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 鎮痛剤のグローバル市場展望 2023年-2029年：非ステロイド性抗炎症薬、中枢性鎮痛薬
  • 非麻酔性鎮痛薬のグローバル市場展望 2023年-2029年：サリチル酸塩、アニリン、ピラゾロン、その他有機酸
  • OTC鎮痛薬のグローバル市場展望 2023年-2029年：アセトアミノフェン、非ステロイド性抗炎症薬（NSAIDs）
  • 腫瘍学（抗がん剤）のグローバル市場展望 2023年-2029年：血液がん、乳がん、消化器がん、前立腺がん、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5813 )"非ステロイド性抗炎症薬（NSAID）のグローバル市場展望 2023年-2029年：サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬" (英文：Non-steroidal Anti-inflammatory Drugs (NSAID) Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。